Skip to main content Scroll Back to Top

Our global life sciences company brings diagnostic testing & drug development together.

Links to LabCorp Specialty Testing Groups

Chemical Testing
Clinical Trials
Coagulation and Endocrinology
Crop Protection
Device and Diagnostics
Drug Development
Kidney Stone Kits
Labcorp OnDemand
MedTox
Monogram
Neurogenetics
Oncology
Paternal and Family DNA Testing
Pathology
Plasma Screening
ViroMed
Women's Health

Utility Menu

Labcorp.com
Login

Search

Search

Main Navigation

Cancer Care Team
- Cancer Care Team
  To deliver optimal patient outcomes
  Products and Services
  Test Menu Featured Tests Sponsored Testing Programs Precision Medicine
  Cancer Type
  Breast Cancer Colorectal Cancer Hematologic Malignancies Hereditary Cancer Lung Cancer Solid Tumor All Other Cancer Types
  Resources
  Test Requisition Forms Laboratory Licenses Order Supplies Specimen Requirements Our Medical Leaders Insurance Coverage
  News & Updates
  News & Events Posters & Publications
Biopharma Partners
Patient Resources
Login
- Login
  - Gold Connect Labcorp Link PATHways
Labcorp.com
Contact Us

Search Diagnostic Test Menu

Breadcrumb

Home
Cancer Care Team
Impact of the updated IPSS-molecular prognostic scoring system for myelodysplastic syndrome in 10,283 real world samples

Poster

Impact of the updated IPSS-molecular prognostic scoring system for myelodysplastic syndrome in 10,283 real world samples

December 2022

Event: ASH 2022

Labcorp Oncology

Biopharma Partners
Cancer Care Team

Login

Gold Connect
Labcorp Link
PATHways

Billing

Bill Pay at Labcorp
Financial Assistance
No Surprises Act

About Us

Our Team
News
Careers
Locations

Contact Us

Contact Us

LabCorp on Linkedin LabCorp on Twitter LabCorp on Facebook LabCorp on YouTube LabCorp on Instagram

Mobile Footer Menu

Labcorp Oncology
- Biopharma Partners
- Cancer Care Team
Login
Billing
About Us
Contact
- Contact Us

LabCorp on Linkedin LabCorp on Twitter LabCorp on Facebook LabCorp on YouTube LabCorp on Instagram

Legal

Combatting Modern Slavery and Human Trafficking Statement
Notice of Nondiscrimination
Privacy Statement
Terms of Use

© 2023 Laboratory Corporation of America® Holdings. All Rights Reserved.